
Novo Nordisk A/S
CSE:NOVO B

Novo Nordisk A/S
Revenue
Novo Nordisk A/S
Revenue Peer Comparison


Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
Revenue
kr244.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
![]() |
H Lundbeck A/S
CSE:HLUN A
|
Revenue
kr19.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
ALK-Abello A/S
CSE:ALK B
|
Revenue
kr4.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
S
|
Stenocare A/S
CSE:STENO
|
Revenue
kr3.8m
|
CAGR 3-Years
167%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Revenue?
Revenue
244.2B
DKK
Based on the financial report for Mar 31, 2024, Novo Nordisk A/S's Revenue amounts to 244.2B DKK.
What is Novo Nordisk A/S's Revenue growth rate?
Revenue CAGR 10Y
11%
Over the last year, the Revenue growth was 30%. The average annual Revenue growth rates for Novo Nordisk A/S have been 24% over the past three years , 16% over the past five years , and 11% over the past ten years .